Clearmind Medicine Inc. has announced the addition of Hadassah-University Medical Center in Jerusalem as a new clinical site for its Phase I/IIa trial of CMND-100, an oral drug candidate aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results